A Phase I Study to Assess Absolute Bioavailability of AZD5672 at Steady-State in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2010
At a glance
- Drugs AZD 5672; AZD 5672
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 Dec 2010 Last checked against ClinicalTrials.gov record.
- 19 Sep 2008 New trial record.